A Pharmacokinetic and Safety Study of Risperidone Long Acting Injectable in Schizophrenic Patients

This study has been completed.
Sponsor:
Information provided by:
Janssen Pharmaceutical K.K.
ClinicalTrials.gov Identifier:
NCT00653406
First received: April 1, 2008
Last updated: May 16, 2011
Last verified: March 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2003
  Estimated Primary Completion Date: No date given